Category: Science


This Engineer is Building a ‘Better’ Biopsy

By Cody R. Barnett, MRA Director of Communications | 20 March 2019 In Science

Biopsies are an important tool to determine if a mole or other lesion is cancerous. For most patients, the occasional biopsy is no big deal. However for patients facing multiple abnormal or otherwise ‘suspicious’ spots in highly visible places the prospect can be daunting. Dr. Jesse Wilson, an MRA-funded investigator, is an engineer on a mission to build a better biopsy.

Read More


Bronze Bodies and Black Lungs: Five Ways the Tanning and Tobacco Industries Use the Same Playbook

By Charles Brodine, MRA Intern | 17 March 2019 In Prevention, Science

Dr. Alan Blum has crusaded against the tobacco industry for 30 years and now he's taking aim at the tanning industry. According to Blum, both the tobacco and tanning industries exploit people in similar ways, by targeting youth, downplaying their own corporate responsibility, infiltrating pop-culture, and indeed, by becoming prolific icons.

Read More


Fight Back Give Back with Clinical Trials

By Cody R. Barnett, MRA Director of Communications | 24 February 2019 In News, Science

When patients understand all of their options, including clinical trials, they can make informed decisions about their care. For many patients, clinical trials represent the best possible way to get access to cutting-edge treatment options.

Read More


Overcoming Targeted Therapy Resistance

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 22 February 2019 In Science, Treatment

Targeted therapies work well for many patients, but most will go on to develop acquired resistance. Researchers are working to address this challenge. Learn about two promising examples.

Read More


It’s Not that Simple: Young Women and Melanoma

By Cody R. Barnett, MRA Director of Communications | 15 February 2019 In Prevention, Science

Article after article describes the ‘skyrocketing’ increases in melanoma among young women. While most are quick to point out the clear association between intentional tanning and skin cancer, few ever hint that there may be more to the story.

Read More


Unchartered Territory: When Should Patients Stop Immunotherapy?

By Cody R. Barnett, MRA Director of Communications | 23 January 2019 In Melanoma Stories, Science, Treatment

For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? In the absence of definitive data – what does indirect data tell us?

Read More


Melanoma Treatment Advances – 2018 in Review

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 18 January 2019 In Science, Treatment

2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.

Read More


Estimated Rates of Melanoma Increasing in 2019

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 9 January 2019 In News, Prevention, Science

The American Cancer Society released updated estimates for the incidence, prevalence, and survival statistics for cancer in the United States. For 2019, ACS estimates that 96,480 people will be diagnosed with melanoma and that 7,230 Americans will die due to the disease. This is an increase of 5.6% and a decrease of 19% from last year respectively.

Read More


MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

By Cody R. Barnett, MRA Director of Communications | 28 November 2018 In News, Science, Treatment

MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.

Read More


Dr. Marc Hurlbert Joins MRA as Chief Science Officer

By Cody R. Barnett, MRA Director of Communications | 20 November 2018 In Science

Dr. Marc Hurlbert has built his career advancing medical research in support of patients. Now, as of this month, he will translate his skills, relationships, and enthusiasm to achieving our mission of ending death and suffering due to melanoma as MRA’s Chief Science Officer.

Read More


Login

×